Albert Einstein College of Medicine - Official

Injectable drugs called biologics are revolutionizing asthma care, targeting the exact immune system pathways causing inflammation. This means better control of symptoms and fewer side effects, helping people reduce attacks and breathe easier. bit.ly/44PncHC

Congratulations to Chandan Guha, M.B.B.S., Ph.D., of Einstein and @MontefioreNYC on being named an @ASTRO_org 2025 Fellow. Dr. Guha—vice chair of radiation oncology at Einstein and Montefiore—was one of 43 fellows named by ASTRO this year. More at bit.ly/4nXzFlw. #MECCC

Last month, Einstein’s office of community engagement and outreach hosted its annual Einstein Enrichment Program (EEP) Poster Presentation Day. EEP, a pathway program for #Bronx high school students, meets throughout the school year. Contact [email protected] to learn more.

Einstein Research led by @MarianneReddan: Our Brains May Detect Others’ Emotions Even If We Misinterpret Them Learn more at bit.ly/3IKjOqk. #Psychiatry #MentalHealthAwareness

Einstein Research led by @aditishasMD and H. Dean Hosgood, Ph.D. | Association Between Air Pollution and Multiple Myeloma Mortality Learn more at bit.ly/4ojCqxN.

DYK New York is experiencing a surge in ticks? Ticks can carry Lyme disease, a serious illness with long-term health effects. Protect yourself by wearing long sleeves in grassy areas, using insect repellent, and checking for ticks after outdoor time. bit.ly/3GNE75l

Burning mouth? Cracked lips? Loss of taste? These might be signs of oral thrush, a yeast infection in the mouth. For @PreventionMag, our Dr. Barry Zingman provides expert insight into the causes, symptoms, treatment, and prevention of oral thrush: bit.ly/4eOQ9Ii

In our study just published in @BloodCancerJnl Outdoor Air Pollution(OAP) , particularly PM2.5 was associated with a trend towards worse survival in #multiplemyeloma patients treated in a historically redlined area - Bronx, NY. @Einstein_SCI @MontefioreNYC @EinsteinMed

Einstein Research: Study Identifies Biomarker that Predicts Response to Anemia Drug for Patients with #MDS. Learn more at: bit.ly/4eXr7Xt.

Just 2️⃣ weeks left to complete the 2025 Community Health Needs Assessment! Launched by our Office of Community and Population Health with @GNYHA, this anonymous survey invites community members & staff to share their input on local health & social needs: gnyhasurveys.org/CHNA

Research led by Syun-Ru Yeh, Ph.D., and her team at Einstein has improved our understanding of how three important enzymes enzymes work at the molecular level. Learn more at bit.ly/4lufkCE. #research #science

Einstein Dean Yaron Tomer, M.D., welcomes you to learn how we prepare students to become knowledgeable, compassionate physicians, and innovative scientific investigators by combining research excellence, humanistic care, and community engagement. bit.ly/4kBFAd2 #MedEd

Sunscreen isn’t one-size-fits-all. If you're wondering the best SPF for your acne, sensitivity, or redness, Dr. Beth McLellan suggests you look beyond SPF and consider how a sunscreen’s formulation works with your skin type. Read @glamourmag: bit.ly/40CBLwP @EinsteinMed

Einstein Research by William R. Jacobs Jr., Ph.D., and colleagues: New Technique Advances Study of #Leprosy More at bit.ly/4lMgFnZ.

How does luspatercept relieve anemia in myelodysplastic syndromes? @srinivas424 @Amitvermamds & team @EinsteinMed discover splicing of erythroid transcription factor is associated with therapeutic response in MDS: jci.org/articles/view/…

Einstein Research: COVID-19’s Effects on Breast Cancer Screening and Outcomes Learn more at bit.ly/3TvhQw8.

Congratulations to Einstein's Joel Friedman, M.D., Ph.D. Vascarta, Inc, an Einstein start-up formed to advance his innovation has advanced his compound for treating #SCD toward clinical trials. @nih_nhlbi has signed a trial agreement with Vascarta. More at prn.to/45XXcMA

We're #MonteProud to be among 3% of hospitals nationwide recognized for excellence in stroke care. Our research and clinical trials have spurred advancements in thrombectomy, giving physicians more time to save brains. @EinsteinMed @NeuroMonteEinst bit.ly/3IqjAUQ

Congratulations to Einstein's Joel Friedman, M.D., Ph.D. Vascarta, Inc, an Einstein start-up formed to advance his innovation has advanced his compound for treating #SCD toward clinical trials. @nih_nhlbihas signed a trial agreement with Vascarta. More at prn.to/45XXcMA.

ICYMI: Montefiore @EinsteinMed Comprehensive Cancer Center and our @BOLD_Program celebrated National Cancer Survivor Day with music, dancing, brunch, and expressions of joy at Marina del Rey in #TheBronx. A beautiful tribute to resilience and hope. 💜